Pilnik Richard D. 4
4 · DiaMedica Therapeutics Inc. · Filed Dec 4, 2020
Insider Transaction Report
Form 4
Pilnik Richard D.
Director
Transactions
- Purchase
Voting Common Shares, no par value per share
2020-12-04$5.50/sh+5,000$27,497→ 65,846 total
Footnotes (1)
- [F1]Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 10,168 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan.